Patents Represented by Attorney John Lamerdin
  • Patent number: 7811791
    Abstract: The present invention provides Interferon-Like (IFN-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing IFN-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: October 12, 2010
    Assignee: Amgen Inc.
    Inventors: Andrew Welcher, Duanzhi Wen, Michael Kelly
  • Patent number: 7629144
    Abstract: The present invention provides novel Secreted Epithelial Colon Stromal-1 (Secs-1) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing Secs-1 polypeptides. The invention further provides methods for the treatment, diagnosis, amelioration, or prevention of diseases associated with Secs-1 polypeptides.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: December 8, 2009
    Assignee: Amgen Inc.
    Inventors: Anthony J. Polverino, Roland Luethy